# ML-Based ABPA Recurrence Prediction and Clinical Utility

> **NCT07714863** · — · RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- ABPA
- Allergic Bronchopulmonary Aspergillosis
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Acute Exacerbation
- Machine Learning

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07714863
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07714863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07714863, "ML-Based ABPA Recurrence Prediction and Clinical Utility". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07714863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*